Haemophagocytic lymphohistiocytosis due to leishmaniasis following anti-tumour necrosis factor-alpha therapy

被引:1
|
作者
Estabrooks, Kristen L. [1 ]
De Silva, Keshani [2 ]
Survela, Lesley [3 ]
Stevenson, William S. [3 ]
机构
[1] Royal Darwin Hosp, Dept Haematol, Darwin, NT, Australia
[2] Royal North Shore Hosp, Dept Anat Pathol, Sydney, NSW, Australia
[3] Royal North Shore Hosp, Dept Haematol, Sydney, NSW, Australia
关键词
D O I
10.1111/bjh.19118
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:497 / 498
页数:2
相关论文
共 50 条
  • [41] Destructive cutaneous leishmaniasis in a patient being treated with anti-tumour necrosis factor-α
    Gurreri, R.
    Pistone, G.
    Bongiorno, M. R.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 : 113 - 113
  • [42] Calcific constrictive pericarditis following tumour necrosis factor-alpha inhibition
    Cunneen, Brian
    Hussein, Hafiz
    O'Sullivan, Jenna
    Yearoo, Ibrahim
    [J]. EUROPEAN HEART JOURNAL-CASE REPORTS, 2024, 8 (02)
  • [43] Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy
    Brennan, FM
    Browne, KA
    Green, PA
    Jaspar, JM
    Maini, RN
    Feldmann, M
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (06): : 643 - 650
  • [44] Myelodysplasia following therapy with tumour necrosis factor-alpha (TNF α) inhibitors -: An uncommon occurence.
    Kamat, Anil V.
    Ezekwesili, Raphael
    El-Miedany, Yasser
    [J]. BLOOD, 2006, 108 (11) : 296B - 296B
  • [45] Anti-Tumor Necrosis Factor-alpha Therapy Provokes Latent Leishmaniasis in a Patient with Rheumatoid Arthritis
    Franklin, Gillian
    Greenspan, Joel
    Chen, Sheng
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2009, 39 (02): : 192 - 195
  • [46] Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
    Konstantinos Papamichael
    Severine Vermeire
    [J]. World Journal of Gastroenterology, 2015, (16) : 4773 - 4778
  • [47] Mycobacterium marinum infection complicated by anti-tumour necrosis factor therapy
    Ramos, Jose M.
    Garcia-Sepulcre, Mariana F.
    Rodriguez, Juan C.
    Padilla, Sergio
    Gutierrez, Felix
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 59 (05) : 617 - 621
  • [48] Anti-tumour necrosis factor a therapy in rheumatoid arthritis: an update on safety
    Hyrich, KL
    Silman, AJ
    Watson, KD
    Symmons, DPM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (12) : 1538 - 1543
  • [49] Anti-tumour necrosis factor therapy and B cells in rheumatoid arthritis
    Leandro, Maria J.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2009, 11 (05)
  • [50] Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
    Papamichael, Konstantinos
    Vermeire, Severine
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (16) : 4773 - 4778